Analysis Group is pleased to announce that Dr. John E. Ware, Jr., an internationally recognized leader in measuring Patient Reported
Outcomes (PRO), has become an academic affiliate.
Dr. Ware’s substantial contributions to the outcomes research field have focused on developing, standardizing, and applying health metrics to assess patient reported outcomes. His work has led to the development of a set of standardized, generic PRO measures, including the SF-36® Health Survey, as well as disease-specific measures such as the Headache Impact Test (HIT-6TM) survey. Dr. Ware frequently provides guidance on evidence support for PRO labeling, and he has been the invited expert for testimony on PRO topics at hearings held by the US Food and Drug Administration. His current research interests also include applying modern psychometric methods to construct more actionable measures, including the first disease-specific quality-of-life (QOL) impact scale standardized across conditions and normed in representative chronically-ill populations.
Dr. Ware is Professor and Chief, Outcomes Measurement Science in the Department of Quantitative Health Sciences at the University of Massachusetts Medical School (UMMS), as well as a member of the National Academy of Medicine (formerly Institute of Medicine). ■